774 reports of this reaction
1.4% of all ABIRATERONE ACETATE reports
#17 most reported adverse reaction
HYPERTENSION is the #17 most commonly reported adverse reaction for ABIRATERONE ACETATE, manufactured by Janssen Biotech, Inc.. There are 774 FDA adverse event reports linking ABIRATERONE ACETATE to HYPERTENSION. This represents approximately 1.4% of all 56,299 adverse event reports for this drug.
Patients taking ABIRATERONE ACETATE who experience hypertension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPERTENSION is a less commonly reported adverse event for ABIRATERONE ACETATE, but still significant enough to appear in the safety profile.
In addition to hypertension, the following adverse reactions have been reported for ABIRATERONE ACETATE:
The following drugs have also been linked to hypertension in FDA adverse event reports:
HYPERTENSION has been reported as an adverse event in 774 FDA reports for ABIRATERONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPERTENSION accounts for approximately 1.4% of all adverse event reports for ABIRATERONE ACETATE, making it a notable side effect.
If you experience hypertension while taking ABIRATERONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.